Accelerated Approval Does Not Accelerate ACIP Recommendation For Prevnar 13 In Adults
Executive Summary
Pfizer still plans to launch Prevnar 13 for adults 50 and older absent an ACIP treatment recommendation, creating an interesting situation for physicians.